Literature DB >> 17851834

Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.

Eleftherios Vairaktaris1, Christos Yapijakis, Christos Tsigris, Stavros Vassiliou, Spyridoula Derka, Emeka Nkenke, Sofia Spyridonidou, Antonis Vylliotis, Eleni Vorris, Vasilis Ragos, Friedrich W Neukam, Efstratios Patsouris.   

Abstract

INTRODUCTION: In light to recently found contribution of factors associated with thrombosis and inflammation to carcinogenesis, we investigated the possible association of angiotensin I- converting enzyme (ACE) with increased risk for oral cancer.
MATERIALS AND METHODS: In DNA samples of 160 patients with oral squamous cell carcinoma and 153 healthy controls of comparable ethnicity, age and sex, we studied the insertion/deletion (I/D) polymorphism in the ACE gene, which affects its transcription.
RESULTS: The I allele frequencies were significantly increased in patients compared to controls, 40.6% versus 27.5% (p < 0.001), respectively. The II homozygotes had a three-fold greater risk for developing oral cancer (odds ratio 3.17, 95% C.I. 1.32-7.61). A significant increase of I alleles was observed in patients regardless their smoking or alcohol consumption habits, early or advanced stage of cancer, presence or absence of a family history for cancer or thrombophilia (Fischer values p < 0.05). DISCUSSION: These findings suggest that the I/D polymorphism, by affecting the ACE gene expression, is associated with the progress of oral oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851834     DOI: 10.1080/02841860701373579

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population.

Authors:  Syed Rizwan Hussain; Mohammad Kaleem Ahmad; Abbas Ali Mahdi; Hena Naqvi; Mohammad Waseem Ahmad; Saurabh Srivastava; Kumud Nigam; Shalini Gupta
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

Review 2.  Association between angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: a meta analysis.

Authors:  Kan Zhang; Dan Cheng; Lingling Yi; Huimin Shi; Guohua Zhen
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis.

Authors:  Yonggang Zhang; Jie He; Yao Deng; Jie Zhang; Xiaobo Li; Zhangpeng Xiang; Honglang Huang; Can Tian; Jin Huang; Hong Fan
Journal:  BMC Med Genet       Date:  2011-12-12       Impact factor: 2.103

Review 4.  Renin angiotensin system and its role in biomarkers and treatment in gliomas.

Authors:  Alexander Perdomo-Pantoja; Sonia Iliana Mejía-Pérez; Liliana Gómez-Flores-Ramos; Montserrat Lara-Velazquez; Cordelia Orillac; Juan Luis Gómez-Amador; Talia Wegman-Ostrosky
Journal:  J Neurooncol       Date:  2018-02-16       Impact factor: 4.130

5.  Associations of the Insertion/Deletion Polymorphism in the ACE Gene and Risk of Gastric Cancer: A Meta-Analysis.

Authors:  Noel Pabalan; Hamdi Jarjanazi; Hilmi Ozcelik
Journal:  J Gastrointest Cancer       Date:  2015-12

6.  Association study indicates combined effect of interleukin-10 and angiotensin-converting enzyme in basal cell carcinoma development.

Authors:  Nikolaos Koronellos; Christos Yapijakis; Alexandros Katoulis; Dimitris Avgoustidis; Antonis Vylliotis; Veronica Papakosta; Stavroula Diamantopoulou; Omiros Zografos; Georgia Vairaktari; Eleftherios Vairaktaris; Stavros Vassiliou
Journal:  Arch Dermatol Res       Date:  2020-08-08       Impact factor: 3.017

7.  No association between angiotensin I converting enzyme (ACE) I/D polymorphism and gastric cancer risk among Japanese.

Authors:  Satoshi Hibi; Yasuyuki Goto; Takafumi Ando; Keitaro Matsuo; Kenji Wakai; Kazuo Tajima; Hidemi Goto; Nobuyuki Hamajima
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.